VTVT
- vTv Therapeutics Inc.
()
Overview
Company Summary
vTv Therapeutics Inc. is a biopharmaceutical company that focuses on the development of innovative treatments for various diseases. The company is primarily engaged in the discovery and development of small molecule drugs, which are designed to target specific biological pathways involved in the pathogenesis of diseases.
vTv Therapeutics' main area of focus is in the field of inflammatory disorders, such as Alzheimer's disease, type 2 diabetes, and psoriasis. They are particularly known for their research and development in the area of Alzheimer's disease, a neurodegenerative disorder that affects millions of people worldwide.
The company develops its drugs based on a science platform called TTP Translational Technology, which allows for the identification of specific molecular targets and the design of drug candidates to modulate these targets. This approach enables vTv Therapeutics to create unique and potentially effective therapies for the targeted diseases.
In addition to its research and development efforts, vTv Therapeutics also carries out clinical trials to evaluate the safety and efficacy of its drug candidates. These trials are conducted in collaboration with medical institutions and regulatory authorities to ensure that the drugs meet the necessary regulatory standards.
Overall, vTv Therapeutics Inc. focuses on discovering and developing novel therapeutics to address unmet medical needs in various diseases, with a particular emphasis on inflammatory disorders like Alzheimer's disease and type 2 diabetes.